in Reproduction


U-11555A is oestrogenic in vaginal smear tests in mice with a low slope and a subcutaneous med of not less than 5 mg. Its oestrogenic activity intravaginally was not fully investigated, but is not high. It is weakly anti-oestrogenic in similar tests, with an med against oestradiol of about 200 μg subcutaneously, perhaps a little lower intravaginally. No interactions were seen as they were with U-11100A† (Emmens & Martin, 1965).

U-11555A has an antifertility action in the mouse when injected on Days 1 to 3 or 4 to 6 of pregnancy, with meds of about 100 μg (Days 1 to 3) and 300μg (Days 4 to 6). In rats, U-11555A has a constant subcutaneous or oral med on Days 1 to 3 or 4 to 6 of about 400 μg. In simultaneous tests in rats, U-11100A had meds of about 20 μg (Days 1 to 3) and 60 μg (Days 4 to 6) and was significantly more potent orally than by injection.

From these results, the antifertility action of U-11555A can hardly be attributed to oestrogenic properties, as was that of U-11100A by Emmens & Martin (1965), and its action profile is not very similar to that of the latter. Its antifertility action in mice is in accord with its anti-oestrogenic potency in that species.

If the inline PDF is not rendering correctly, you can download the PDF file here.


     An official journal of

    Society for Reproduction and Fertility


Sept 2018 onwards Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 129 16 1
PDF Downloads 72 23 1